BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 21177806)

  • 41. Fuse me IFITM can!
    Fassati A
    Retrovirology; 2014 Nov; 11():104. PubMed ID: 25422110
    [No Abstract]   [Full Text] [Related]  

  • 42. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
    John SP; Chin CR; Perreira JM; Feeley EM; Aker AM; Savidis G; Smith SE; Elia AE; Everitt AR; Vora M; Pertel T; Elledge SJ; Kellam P; Brass AL
    J Virol; 2013 Jul; 87(14):7837-52. PubMed ID: 23658454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1 mutates to evade IFITM1 restriction.
    Ding S; Pan Q; Liu SL; Liang C
    Virology; 2014 Apr; 454-455():11-24. PubMed ID: 24725927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.
    Wilkins J; Zheng YM; Yu J; Liang C; Liu SL
    PLoS One; 2016; 11(6):e0156739. PubMed ID: 27257969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opposing activities of IFITM proteins in SARS-CoV-2 infection.
    Shi G; Kenney AD; Kudryashova E; Zani A; Zhang L; Lai KK; Hall-Stoodley L; Robinson RT; Kudryashov DS; Compton AA; Yount JS
    EMBO J; 2021 Feb; 40(3):e106501. PubMed ID: 33270927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The IFITMs Inhibit Zika Virus Replication.
    Savidis G; Perreira JM; Portmann JM; Meraner P; Guo Z; Green S; Brass AL
    Cell Rep; 2016 Jun; 15(11):2323-30. PubMed ID: 27268505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host antiviral protein IFITM2 restricts pseudorabies virus replication.
    Xie J; Bi Y; Xu S; Han Y; Idris A; Zhang H; Li X; Bai J; Zhang Y; Feng R
    Virus Res; 2020 Oct; 287():198105. PubMed ID: 32745511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.
    Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
    Spence JS; He R; Hoffmann HH; Das T; Thinon E; Rice CM; Peng T; Chandran K; Hang HC
    Nat Chem Biol; 2019 Mar; 15(3):259-268. PubMed ID: 30643282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFITM1 and IFITM2 inhibit the replication of senecavirus A by positive feedback with RIG-I signaling pathway.
    Li H; Chen M; Zheng T; Lei X; Lin C; Li S; Mo J; Ning Z
    Vet Microbiol; 2024 May; 292():110050. PubMed ID: 38484578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. G3BP1 and G3BP2 regulate translation of interferon-stimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7.
    Alam U; Kennedy D
    Mol Cell Biochem; 2019 Sep; 459(1-2):189-204. PubMed ID: 31172368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
    Shi G; Ozog S; Torbett BE; Compton AA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10069-E10078. PubMed ID: 30301809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection.
    Muñoz-Moreno R; Cuesta-Geijo MÁ; Martínez-Romero C; Barrado-Gil L; Galindo I; García-Sastre A; Alonso C
    PLoS One; 2016; 11(4):e0154366. PubMed ID: 27116236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
    Tartour K; Appourchaux R; Gaillard J; Nguyen XN; Durand S; Turpin J; Beaumont E; Roch E; Berger G; Mahieux R; Brand D; Roingeard P; Cimarelli A
    Retrovirology; 2014 Nov; 11():103. PubMed ID: 25422070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.
    Warren CJ; Griffin LM; Little AS; Huang IC; Farzan M; Pyeon D
    PLoS One; 2014; 9(5):e96579. PubMed ID: 24827144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
    Weidner JM; Jiang D; Pan XB; Chang J; Block TM; Guo JT
    J Virol; 2010 Dec; 84(24):12646-57. PubMed ID: 20943977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of IFITM1 and IFITM3 in Goose: Gene Structure, Expression Patterns, and Immune Reponses against Tembusu Virus Infection.
    Wang A; Sun L; Wang M; Jia R; Zhu D; Liu M; Sun K; Yang Q; Wu Y; Chen X; Cheng A; Chen S
    Biomed Res Int; 2017; 2017():5149062. PubMed ID: 28386554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.
    Beitari S; Pan Q; Finzi A; Liang C
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Leukocyte Expression of
    Regino-Zamarripa NE; Ramírez-Martínez G; Jiménez-Álvarez LA; Cruz-Lagunas A; Gómez-García IA; Ignacio-Cortés S; Márquez-García JE; Pacheco-Hernández LM; Ramírez-Noyola JA; Barquera R; Mendoza-Milla C; Luna-Rivero C; Domínguez-Cherit JG; Ramírez-Rangel R; Rodríguez-Reyna TS; Hernández-Cárdenas CM; Choreño-Parra JA; León-Ávila G; Zúñiga J
    J Interferon Cytokine Res; 2022 Aug; 42(8):430-443. PubMed ID: 35708622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.